The in vivo application of the anti-inflammatory and insulin-sensitizing effects associated with GPR120 stimulation, which are promising tools for the prevention and treatment of obesity, is very difficult [233]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.